RecruitingPhase 2NCT05886036
Blood
Nodular lymphocyte predominant Hodgkin lymphoma
2
studies recruiting now
as of 7 Sept 2026
40
studies registered in total
as of 7 Sept 2026
2
countries with a recruiting site
as of 7 Sept 2026
24 Oct 2023
most recent study posted
among recruiting studies
Recruiting trials
RecruitingNCT06098430
Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
Showing the 2 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
Search all Nodular lymphocyte predominant Hodgkin lymphoma studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Nodular lymphocyte predominant Hodgkin lymphoma study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Nodular lymphocyte predominant Hodgkin lymphoma
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Treatments being studied
18 approved treatments and 85 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Approved: Doxorubicin Hydrochloride (Adriamycin)Approved: Bleomycin Sulfate (Blenoxane)Approved: ProcarbazineApproved: Cyclophosphamide (Cyclophosphamide)Approved: Nivolumab (Nivolumab bms)Approved: Tislelizumab (Tevimbra)Approved: Sintilimab (Tyvyt)Approved: Thiotepa (Tepadina)Approved: Carmustine (Bicnu)Approved: Brentuximab Vedotin (Adcetris)Approved: Dacarbazine (Dacarbazine)Approved: Vinblastine Sulfate (Velban)Approved: Melphalan (Alkeran)Approved: Chlorambucil (Leukeran)Approved: Pembrolizumab (Keytruda)Approved: Bleomycin (Bleo)Approved: Lomustine (Ccnu)Approved: Gallium Citrate Ga 67 (Gallium citrate ga 67)
Phase 3Etoposide (Etoposide)
Phase 3Panobinostat (Farydak)
Phase 3Dexamethasone (Aeroseb-dex)
Phase 3Filgrastim (Accofil)
Phase 3Plerixafor (Mozobil)
Phase 3Vinblastine
Phase 3Doxorubicin (Adriblastina)
Phase 3Vincristine
+ 77 more in development
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).